#France #Colorectal Surgery #Qaelon Medical #Strasbourg #Dr. Marylise Boutros

Qaelon Medical Welcomes Dr. Marylise Boutros to its Scientific Advisory Board

Qaelon Medical, a leading innovator in the realm of surgical leak detection and advanced insufflation technology, made news today with the announcement of Dr. Marylise Boutros's appointment to its Scientific Advisory Board (SAB). This decision comes as part of Qaelon’s strategy to strengthen its clinical insights and advance its technological offerings in the surgical field.

Dr. Marylise Boutros is an esteemed colorectal surgeon known for her exceptional contributions to the field, especially from her position at the Digestive Disease Institute at Cleveland Clinic Florida. Her research, particularly in the areas of colorectal surgery, multicenter clinical trials, and development of clinical guidelines, has positioned her as a sought-after expert.

Joining Dr. Boutros on the advisory board are other significant figures in the medical community, including Andrew Storm, MD, FASGE, and Joel Dunning, MD, who bring their own wealth of experience to the team.

Eran Shlomovitz, MD, the Chief Medical Officer and founder of Qaelon Medical, expressed his enthusiasm about Dr. Boutros’s contributions. He pointed out her pivotal role in shaping the surgical community’s understanding of anastomotic leaks through efforts such as the CoReAL consensus framework. Her research has highlighted the long-term impacts of these leaks on patients’ quality of life, shedding light on crucial conditions like Low Anterior Resection Syndrome (LARS).

In her new role, Dr. Boutros will lend her expertise to help develop Qaelon's clinical strategies, steering projects aimed at refining leak detection and localization standards during gastrointestinal and colorectal surgeries. Her past successes in obtaining peer-reviewed grants and increasing the number of active clinical trials are indicative of her leadership abilities and dedication to advancing healthcare.

“I am truly excited to be a part of Qaelon’s Scientific Advisory Board,” Dr. Boutros declared. “Anastomotic leaks have persistently been a challenge in surgical practices, largely due to the uncertainty these issues generate. The technology developed by Qaelon provides a remarkable opportunity to introduce clarity and transparency in surgical procedures. I am eager to utilize my expertise in colorectal surgery to enhance the understanding of surgical leaks through real-time data and localized observations.”

Liam Burns, CEO of Qaelon Medical, reiterated the company’s vision of modernizing surgical leak detection by integrating real-world evidence and establishing proactive insights. He emphasizes the significance of having a board filled with leading clinicians and researchers to uphold their commitment to revolutionizing surgical standards.

Qaelon Medical, headquartered in Strasbourg, France, is on a mission to pioneer surgical leak detection technology. Its innovative approach combines real-time, AI-assisted detection with advanced insufflation techniques. By replacing outdated methods with sophisticated digital sensors and algorithms, Qaelon aims to minimize complications and healthcare costs while improving patient outcomes.

As Qaelon continues to progress in its groundbreaking initiatives, the inclusion of Dr. Boutros on its advisory board illustrates a clear commitment to integrating clinical expertise into its business strategies. It will be fascinating to observe the forthcoming advancements resulting from this collaboration and the potential benefits patients can receive from improved surgical practices.

To find out more about Qaelon Medical and the exciting developments underway, visit their official website at www.qaelonmedical.com.